Xeris Biopharma Holdings Inc. buy Piper Sandler
Start price
10.11.23
/
50%
€1.60
Target price
10.11.24
€3.74
Performance (%)
99.88%
End price
11.11.24
€3.20
Summary
This prediction ended on 11.11.24 with a price of €3.20. With a performance of 99.88% the BUY prediction by Piper_Sandler was a big success. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Xeris Biopharma Holdings Inc. | - | - | 32.438% |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % |
Comments by Piper_Sandler for this prediction
In the thread Xeris Biopharma Holdings Inc. diskutieren
Xeris Biopharma Holdings, Inc. (NASDAQ: XERS) had its price target lowered by analysts at Piper Sandler from $5.00 to $4.00. They now have an "overweight" rating on the stock.
Ratings data for XERS provided by MarketBeat
In the thread Trading Xeris Biopharma Holdings Inc.
Die von Piper_Sandler gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Piper_Sandler for Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc.
Start price
Target price
Perf. (%)
€1.64
10.05.24
10.05.24
€2.78
10.05.25
10.05.25
188.96%
11.05.25
11.05.25
